WASHINGTON, D.C. (Monday, June 21, 2010) - Today the Biotechnology Industry Organization (BIO) announced that Bob Dayton, president of the Delaware BioScience Association, has been appointed to the Executive Committee of the Council of State Bioscience Associations (CSBA), an autonomous council operating within BIO.
As an Executive Committee member, Dayton will be representing the interests of CSBA members within his region of the country – comprising Pennsylvania, New Jersey, Delaware, Maryland, District of Columbia, West Virginia and Virginia. The seven-state region accounts for approximately 17 percent of the total bioscience jobs in the country.
"BIO works closely with CSBA member organizations to improve understanding of the bioscience industry and advocate for policies that help promote industry development throughout the United States," said Patrick Kelly, Vice President of State Government Relations and Alliance Development at BIO. "Through the recent economic downturn, this network has played the instrumental role of working with state legislatures in addressing the need for continued investment in the growth of this high-paying, jobs-producing industry."
The CSBA is a confederation of 47 state-based, non-profit trade organizations each governed by its own board of directors. The mission of the CSBA is to promote public understanding, and to advocate for public policies that support the responsible development of the bioscience industry. These groups are recognized by BIO as affiliate organizations in their respective states.
Upcoming BIO Events
World Congress on Industrial Biotechnology and Bioprocessing
June 27-30, 2010
September 21 - 22, 2010
BIO’s Livestock Biotechnology Summit
September 28-30, 2010,
Sioux Falls, SD
BIO Investor Forum
October 5-6, 2010
San Francisco, CA
BIO Intellectual Property Counsels Committee Fall Conference and Committee Meeting
October 18-20, 2010
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.